Literature DB >> 19493152

Does left atrial volume and pulmonary venous anatomy predict the outcome of catheter ablation of atrial fibrillation?

Irene Hof1, Karuna Chilukuri, Armin Arbab-Zadeh, Daniel Scherr, Darshan Dalal, Saman Nazarian, Charles Henrikson, David Spragg, Ronald Berger, Joseph Marine, Hugh Calkins.   

Abstract

INTRODUCTION: Preprocedural factors may be helpful in selecting patients with atrial fibrillation (AF) for treatment with catheter ablation and in making an assumption regarding their prognosis. The aims of this study were to investigate whether left atrial (LA) volume and pulmonary venous (PV) anatomy, evaluated by computed tomography (CT) prior to ablation, will predict AF recurrence following catheter ablation. METHODS AND
RESULTS: We included 146 patients (mean age 57 +/- 11 years, 83% male) with symptomatic AF (55% paroxysmal, 18% persistent, 27% long-standing persistent). All patients underwent CT scanning prior to catheter ablation to evaluate LA volume and PV anatomy. Circumferential PV isolation was performed guided by Cartomerge electroanatomical mapping. The outcome was defined as complete success, improvement, or failure. After a mean follow-up of 19 +/-7 months, complete success was achieved in 59 patients (40%), and 38 patients (26%) demonstrated improvement. LA volume was found to be an independent predictor of AF recurrence with an adjusted OR of 1.14 for every 10-mL increase in volume (95% CI 1.00-1.29, P = 0.047). PV variations were equally distributed among the different outcomes of the ablation procedure, and therefore univariate analysis did not identify PV anatomy as a predictor of outcome.
CONCLUSION: LA volume is an independent predictor of AF recurrence after catheter ablation. Additionally, PV anatomy did not have any effect on the outcome. These findings suggest that an assessment of LA volume may be incorporated into the preprocedural evaluation of patients being considered for AF ablation.

Entities:  

Mesh:

Year:  2009        PMID: 19493152     DOI: 10.1111/j.1540-8167.2009.01504.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  47 in total

Review 1.  Left atrial volume: clinical value revisited.

Authors:  Michael Y C Tsang; Marion E Barnes; Teresa S M Tsang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

2.  Atrial conduction times and left atrium mechanical functions in patients with active acromegaly.

Authors:  A Ilter; A Kırış; Ş Kaplan; M Kutlu; M Şahin; C Erem; N Civan; F Kangül
Journal:  Endocrine       Date:  2014-07-15       Impact factor: 3.633

3.  Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation.

Authors:  Hirohiko Motoki; Kazuaki Negishi; Kenya Kusunose; Zoran B Popović; Mandeep Bhargava; Oussama M Wazni; Walid I Saliba; Mina K Chung; Thomas H Marwick; Allan L Klein
Journal:  J Am Soc Echocardiogr       Date:  2014-09-23       Impact factor: 5.251

Review 4.  [Cardiac computed tomography and ablation of atrial fibrillation].

Authors:  Martin Schmidt; F Straube; U Ebersberger; U Dorwarth; M Wankerl; J Krieg; E Hoffmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-12-05

5.  Left atrial volume and dominant frequency of atrial fibrillation in patients undergoing catheter ablation of persistent atrial fibrillation.

Authors:  Kentaro Yoshida; Amir B Rabbani; Hakan Oral; David Bach; Fred Morady; Aman Chugh
Journal:  J Interv Card Electrophysiol       Date:  2011-06-14       Impact factor: 1.900

Review 6.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

7.  Prolonged total atrial conduction time evaluated with tissue Doppler imaging predicts poor cardiac prognosis in patients with heart failure.

Authors:  Gensai Yamaura; Tetsu Watanabe; Harutoshi Tamura; Hayato Tsuchiya; Naoto Hashimoto; Masahiro Wanezaki; Satoshi Nishiyama; Takanori Arimoto; Hiroki Takahashi; So Yamauchi; Tetsuro Shishido; Tamon Yamanaka; Takuya Miyamoto; Masafumi Watanabe
Journal:  Heart Vessels       Date:  2019-04-26       Impact factor: 2.037

8.  Impact of Pulmonary Vein Anatomy on Long-term Outcome of Cryoballoon Ablation for Atrial Fibrillation.

Authors:  Shang-Wei Huang; Qi Jin; Ning Zhang; Tian-You Ling; Wen-Qi Pan; Chang-Jian Lin; Qing-Zhi Luo; Yan-Xin Han; Li-Qun Wu
Journal:  Curr Med Sci       Date:  2018-04-30

9.  Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.

Authors:  Xin-Xin Ma; Yue-Li Zhang; Bing Hu; Wen-Jun Jiang; Man Wang; Dong-Yan Zheng; Meng-Ruo Zhu; Xiao-Pei Xue
Journal:  J Interv Card Electrophysiol       Date:  2016-12-12       Impact factor: 1.900

10.  Centerline tracking for quantification of reverse structural remodeling of the pulmonary veins following cardiac ablation therapy.

Authors:  Maryam E Rettmann; Mia S Gunawan; David R Holmes; Jerome F Breen; Douglas L Packer; Richard A Robb
Journal:  Acad Radiol       Date:  2012-08-11       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.